NASDAQ:CUE
Cue Biopharma, Inc.
- Stock
Last Close
1.74
17/05 20:00
Market Cap
119.13M
Beta: 2.00
Volume Today
116.01K
Avg: 186.50K
PE Ratio
−2.14
PFCF: −2.73
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
net income | -1.93M - | -7.66M 297.06% | -23.23M 203.38% | -38.98M 67.77% | -36.70M 5.85% | -44.78M 22.03% | -44.16M 1.39% | -53.01M 20.04% | -50.73M 4.30% | |
depreciation and amortization | 44.81K - | 202.09K 350.93% | 419.57K 107.62% | 760.01K 81.14% | 5.17M 579.67% | 1.06M 79.53% | -1.78M 268.14% | 1.81M 201.58% | 3.44M 90.25% | |
deferred income tax | 10.68K - | 79.86K 647.95% | -18.19K 122.78% | 83.69K 560.11% | ||||||
stock based compensation | 889.56K - | 2.78M 211.99% | 7.17M 158.48% | 6.52M 9.10% | 10.48M 60.72% | 11.52M 9.87% | 9.50M 17.54% | |||
change in working capital | 146.80K - | 532.32K 262.61% | 2.91M 446.48% | 4.21M 44.75% | -1.49M 135.36% | 1.23M 182.76% | -4.39M 456.07% | 356.27K 108.12% | -934K 362.16% | |
accounts receivables | -754.90K - | -662.58K 12.23% | -1.73M 160.35% | 3.09M 278.85% | -1.64M 153.19% | |||||
inventory | -509.80K - | 4.85M 1,051.90% | 4.79M 1.28% | |||||||
accounts payables | 177.81K - | 561.59K - | 376.15K 33.02% | -1.15M 406.45% | 741.26K 164.31% | 520.40K 29.80% | 83.11K 84.03% | 770K 826.48% | ||
other working capital | -31.01K - | 532.32K 1,816.50% | 2.35M 340.98% | 3.83M 63.35% | 928.59K 75.78% | -3.70M 498.37% | -7.97M 115.54% | -2.81M 64.73% | -63K 97.76% | |
other non cash items | 79.55K - | 65.91K 17.14% | 4.93M 7,376.40% | 345.10K 93.00% | -4.28M 1,339.50% | -563.23K 86.83% | -26.13K 95.36% | -453.78K 1,636.55% | 8.27M 1,922.48% | |
net cash provided by operating activities | -1.66M - | -5.97M 260.07% | -12.19M 104.27% | -26.41M 116.63% | -30.80M 16.61% | -32.49M 5.51% | -38.84M 19.52% | -41.81M 7.64% | -39.96M 4.41% | |
investments in property plant and equipment | -754.29K - | -515.98K 31.59% | -1.20M 133.53% | -1.85M 53.89% | -46.35K 97.50% | -595.26K 1,184.19% | -913.04K 53.39% | -170.75K 81.30% | ||
acquisitions net | 127.50K - | 83.69K 34.36% | 4.58K 94.53% | 6.21K 35.45% | 2K 67.77% | |||||
purchases of investments | -39.50M - | -15.13M 61.69% | -9.95M 34.26% | -4.58K 99.95% | -29.45M 642,670.92% | |||||
sales maturities of investments | 21M - | 18.50M 11.90% | 15M 18.92% | 10M 33.33% | 5M 50% | 25M 400% | ||||
other investing activites | -50K - | -33 99.93% | -35 6.06% | -83.69K - | 21.55K 125.75% | |||||
net cash used for investing activites | -804.29K - | -516.01K 35.84% | -1.20M 133.52% | -20.35M 1,589.18% | 3.45M 116.93% | 4.46M 29.27% | 9.11M 104.42% | -24.61M 370.19% | 25.00M 201.59% | |
debt repayment | -141.75K - | -2M 1,310.94% | ||||||||
common stock issued | 10.00M - | 16.41M 64.09% | 66.16M 303.02% | 4.17M 93.70% | 49.00M 1,075.22% | 56.68M 15.68% | 17.38M 69.33% | 39.30M 126.07% | 13.86M 64.73% | |
common stock repurchased | -1.14M - | -1.41M 23.93% | -4.16M 195.06% | -91.03K - | -271.05K 197.77% | -750.18K 176.77% | -199.87K 73.36% | |||
dividends paid | -199.87K - | |||||||||
other financing activites | 1K - | 9.01K - | 12.50K 38.77% | 1.88M 14,955.08% | 2.20M 17.07% | 2.60M 17.96% | 14.90M 473.33% | |||
net cash used provided by financing activities | 8.87M - | 15.01M 69.22% | 62.00M 313.22% | 4.18M 93.26% | 50.79M 1,114.53% | 58.61M 15.41% | 19.23M 67.19% | 53.66M 178.99% | 11.86M 77.90% | |
effect of forex changes on cash | -1.10K - | |||||||||
net change in cash | 6.41M - | 8.52M 33.03% | 48.61M 470.47% | -42.58M 187.61% | 23.44M 155.04% | 30.58M 30.45% | -10.50M 134.33% | -12.76M 21.55% | -3.10M 75.70% | |
cash at beginning of period | 6.41M - | 14.93M 133.03% | 63.58M 326.00% | 21.00M 66.97% | 44.44M 111.62% | 75.02M 68.80% | 64.52M 13.99% | 51.61M 20.00% | ||
cash at end of period | 6.41M - | 14.93M 133.03% | 63.53M 325.66% | 21.00M 66.95% | 44.44M 111.62% | 75.02M 68.80% | 64.52M 13.99% | 51.76M 19.77% | 48.51M 6.28% | |
operating cash flow | -1.66M - | -5.97M 260.07% | -12.19M 104.27% | -26.41M 116.63% | -30.80M 16.61% | -32.49M 5.51% | -38.84M 19.52% | -41.81M 7.64% | -39.96M 4.41% | |
capital expenditure | -754.29K - | -515.98K 31.59% | -1.20M 133.53% | -1.85M 53.89% | -46.35K 97.50% | -595.26K 1,184.19% | -913.04K 53.39% | -170.75K 81.30% | ||
free cash flow | -2.41M - | -6.48M 168.85% | -13.40M 106.60% | -28.27M 110.99% | -30.84M 9.12% | -33.09M 7.28% | -39.75M 20.13% | -41.98M 5.60% | -39.96M 4.80% |
All numbers in USD (except ratios and percentages)